GB
11
Projects
3
Coordinated
8
As Partner
€548,428
Total Budget
Budget Range
Min
€18,111
Average
€49,857
Max
€79,493
Role Distribution
Sector Distribution
Budget by Sector (€)
Projects (11)
P
Identification of novel viral entry factors and development of antiviral approaches
Health101191666
€79,493
C
Effect of long-acting spatial repellents (LASR) vs indoor residual spraying (IRS) on malaria burden in western Kenya: a cluster-randomised trial
Health101190818
€60,321
P
Telacebec to Control Buruli Ulcer and Leprosy in Africa (TEBULA)
Health101190742
€57,684
P
Building multidisciplinary evidence to support Integrating Malaria VACcine with Seasonal malaria chemoprevention in West Africa
Health101160339
€57,367
C
R21/M-Malaria vaccine to extend the protection of Post-Discharge Malaria Chemoprevention in children recovering from severe anaemia: a randomised-controlled trial in Malawi, Kenya and Uganda
Health101190602
€53,251
P
SAFETY OF ANTIMALARIALS IN THE FIRST TRIMESTER: AN ADAPTIVE PLATFORM TRIAL
Health101145740
€51,914
C
REPURPOSING FUSIDIC ACID AS A SHORT-COURSE ONCHOCERCA VOLVULUS MACROFILARICIDE: A RANDOMIZED CONTROLLED OPEN-LABEL PARALLEL GROUP INTERVENTION PHASE IIA/B PILOT TRIAL
Health101190778
€51,217
P
Post-discharge malaria chemoprevention in children with severe anaemia in Benin, Kenya, Malawi and Uganda: Formative and implementation research for policy decision making and implementation
Health101103078
€45,311
P
Mitigating Antimalarial Resistance Consortium in South-East Africa
Health101103076
€41,706
P
Drug Optimisation in LMICs of Pregnant HIV women and their Infants: temporary switch to CAB/RPV long acting injections
Health101145722
€32,052
P
PREVENTING AND DELAYING THE DEVELOPMENT OF DIABETES IN AFRICA: A RANDOMISED PLACEBO -CONTROLLED DOUBLE-BLIND PHASE III TRIAL OF METFORMIN IN HIV-INFECTED PERSONS WITH PRE-DIABETES
Health101145764
€18,111